Fate Therapeutics Inc (FATE)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Redmile	$3.72	44,630	Large Shareholder, Director	13,180,388	2023-12-26	Filing
Redmile	$6.18	256,639	Large Shareholder, Director	13,135,758	2023-04-21	Filing
Redmile	$5.99	20,000	Large Shareholder, Director	12,879,119	2023-04-20	Filing
Redmile	$6.00	25,700	Large Shareholder, Director	12,859,119	2023-04-14	Filing
Mendlein	$5.43	36,631	Director	282,770	2023-01-13	Filing
Mendlein	$5.67	88,048	Director	246,139	2023-01-11	Filing
Redmile	$85.50	327,485	Large Shareholder, Director	12,957,222	2021-01-08	Filing
Redmile	$28.31	1,412,928	Large Shareholder, Director	12,629,737	2020-06-11	Filing
Redmile	$17.50	857,143	Large Shareholder, Director	11,216,809	2019-09-16	Filing
Redmile	$13.50	3,703,704	Large Shareholder, Director	10,359,666	2018-09-25	Filing
Storgard	$2.66	37,593	Officer	37,593	2016-11-23	Filing
Rastetter	$2.66	375,939	Director	459,272	2016-11-23	Filing
Coughlin	$2.66	56,390	Director	56,390	2016-11-23	Filing
Venrock	$6.00	833,333	Large Shareholder	2,473,187	2013-10-04	Filing
Polaris	$6.00	8,041	Large Shareholder	2,473,186	2013-10-04	Filing
Polaris	$6.00	5,508	Large Shareholder	2,465,145	2013-10-04	Filing
Polaris	$6.00	15,672	Large Shareholder	2,459,637	2013-10-04	Filing
Polaris	$6.00	804,112	Large Shareholder	2,443,965	2013-10-04	Filing
Nashat	$6.00	8,041	Large Shareholder, Director	2,473,186	2013-10-04	Filing
Nashat	$6.00	5,508	Large Shareholder, Director	2,465,145	2013-10-04	Filing